A venom fraction from the Philippine tarantula (Orphnaecus sp.) reveals low-molecular-weight compounds that potentiate drug-like neurobehavioral responses in Danio rerio
ABSTRACT
Background: Spider venoms are wealthy pure sources of bioactive chemical substances starting from low-molecular-mass compounds to bigger molecules comparable to low molecular mass peptides, proteins, and enzymes. Some compounds have been reported to exhibit neuroactivity and present potential as therapeutic brokers towards neurological issues. Thus, this research analyzed the neurobehavioral results of chosen venom fractions from Philippine tarantula species in comparison with FDA-approved medication concentrating on neuroreceptors, ion channels, and enzymes.
Strategies: The venom was collected from the tarantula by electrostimulation and fractionated by reverse-phase high-performance liquid chromatography (RP-HPLC). 9 of the eleven fractions have been subjected to neurobehavioral evaluation utilizing zebrafish (Danio rerio) because the animal mannequin. The fractions have been administered intraperitoneally, and their neurobehavioral results have been examined utilizing the novel tank check, worry response, social interplay, and mirror biting checks. Donepezil, lidocaine, and diazepam have been used as optimistic controls, and regular saline answer (NSS) because the adverse management of the research. The swimming patterns and trajectories of the zebrafish have been monitored utilizing idTracker and have been graphed utilizing GraphPad Prism v.9.0. Elements of essentially the most polar fraction have been additional analyzed by Extremely Efficiency Liquid Chromatography – Quadrupole Time of Flight Information Dependent Evaluation to determine the elements structurally.
Outcomes: Preliminary screening of all of the fractions revealed that Fraction 1 with 0.1 µg/µL exhibited donepezil-like conduct based mostly on comparable rapid-swimming motion from 0 to 31 time intervals, Fraction 4 with 0.1 µg/µL focus exhibited diazepam-like conduct attributable to non-significant variations in its time spent on high of the tank ranging from20 to 40 minutes, and Fraction 8 with 0.1 µg/µL focus exhibited lidocaine-like conduct based mostly on each fast swimming motion and time spent on high of the tank. Fractions 1, 4, and eight have been additional evaluated by figuring out their dose-dependent response, which follows the impact of their corresponding optimistic management. Evaluation of Fraction 1 resulted within the annotation of a number of non-peptidic elements 4-OH-PhLac434 and its isomer utilizing VenoMS and isopimaric acid, palmitamide, 9-octadecenamide, and 13-docosenamide as putative compounds current on this spider venom utilizing GNPS.
Conclusion: Total, the fractions of venom from the Orphnaecus tarantula species seem to induce distinct neurobehavioral results, which can embrace hyperactivity, anxiolytic-like responses, and potential antinociceptive properties.
Bautista, J. L. C., Abellanosa, E. A. M., Molino, R. E. J., Jardiolin, J. G., Calpo, R. A. A., Devanadera, M. Ok. P., Mayor, A. B. R., Nuñeza, O. M., Acuña, D. C., Rodriguez, C., Santiago-Bautista, M. R., Peña, G. T., Junio, H. A., & Guevarra Jr, L. A.. (2026). A venom fraction from the Philippine tarantula (Orphnaecus sp.) reveals low-molecular-weight compounds that potentiate drug-like neurobehavioral responses in Danio rerio. Journal of Venomous Animals and Toxins Together with Tropical Ailments, 32, e20240063. https://doi.org/10.1590/1678-9199-JVATITD-2024-0063
